Delivery Order SPE2DB20D3103-SPE2DB24FP9Q0
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,253.69 firm fixed-price delivery order contract has a completion date of February 25, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $17,172.33 and is a firm fixed-price delivery order with a final completion date of February 20, 2024. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,028.03 firm fixed-price delivery order has a completion date of November 19, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $79,621.50 and a completion date of June 4, 2024. The award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
The federal contract award is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The fixed-price delivery order has a ceiling value of $20,513.52 and a completion date of January 8, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, which was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,814.17, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 23, 2024. The award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,800.21 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 26, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, with a ceiling value of $34,846.54. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as...
This federal contract award is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, with a ceiling value of $9,980.55. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $61,796.23 and an ultimate completion date of February 29, 2024. The contract is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...